Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
10 studies found for:    M2e
Show Display Options
Rank Status Study
1 Completed
Has Results
Comparative Safety and Immunogenicity of 1.0 µg Intramuscular (i.m.) and 2.0 µg Subcutaneous (s.c.) Dosing With VAX102 (M2e-flagellin) Universal Influenza Vaccine in Healthy Adults
Condition: Influenza
Intervention: Biological: VAX102
2 Completed More-2-Eat; Implementation of INPAC
Condition: Acute Care Medical
3 Completed
Has Results
Safety Study of Recombinant M2e Influenza-A Vaccine in Healthy Adults
Condition: Influenza
Interventions: Biological: Influenza A Vaccine: ACAM FLU-A;   Biological: Saline placebo
4 Completed Phase I Safety and Immunogenicity Study of VAX102 [Flagellin.HuM2e] Influenza Vaccine in Healthy Adults
Condition: Influenza Infection
Interventions: Biological: VAX102 [Flagellin.HuM2e];   Biological: Placebo
5 Completed Study to Investigate the Immune Response to Two Doses of VAX102 Healthy Adults
Condition: Influenza
Intervention: Biological: VAX102
6 Completed Study Of VGX-3400, H5N1 Avian Flu Virus Plasmid DNA With Electroporation Device In Healthy Adult Males
Condition: Healthy
Intervention: Biological: VGX-3400
7 Completed Genetic Expression and Prediction of Response to Neoadjuvant Docetaxel or Doxorubicin in Locally Advanced Breast Cancer
Condition: Breast Cancer
Interventions: Drug: docetaxel;   Drug: doxorubicin
8 Completed Dose-Finding Study of E7070 in Combination With Irinotecan
Condition: Cancer
Interventions: Drug: E7070 + irinotecan combination;   Drug: Irinotecan + E7070 combination
9 Completed Safety Study of Anti-Influenza Virus Monoclonal Antibody to Treat Influenza
Condition: Influenza, Human
Interventions: Biological: TCN-032;   Biological: Placebo
10 Completed Pethema Multiple Myeloma 2000
Condition: Multiple Myeloma
Interventions: Drug: Alternating chemotherapy;   Procedure: Autologous Transplantation;   Drug: Maintenance;   Procedure: Second transplantation;   Procedure: ALOGENIC MINI TRASPLANTATION

Study has passed its completion date and status has not been verified in more than two years.